Łukasz Biegała
3PUBLICATIONS
9CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Jan 25, 2025
Olaparib Combined with DDR Inhibitors Effectively Prevents EMT and Affects miRNA Regulation in TP53-Mutated Epithelial Ovarian Cancer Cell Lines.Patrycja Gralewska, Łukasz Biegała, Arkadiusz Gajek
|May 24, 2024
Uncovering miRNA-mRNA Regulatory Networks Related to Olaparib Resistance and Resensitization of BRCA2MUT Ovarian Cancer PEO1-OR Cells with the ATR/CHK1 Pathway Inhibitors.Łukasz Biegała, Damian Kołat, Arkadiusz Gajek
|Apr 13, 2023
Olaparib-Resistant BRCA2MUT Ovarian Cancer Cells with Restored BRCA2 Abrogate Olaparib-Induced DNA Damage and G2/M Arrest Controlled by the ATR/CHK1 Pathway for Survival.Łukasz Biegała, Arkadiusz Gajek, Agnieszka Marczak
Pageof 1
Frequent Collaborators
3 joint publications
Arkadiusz Gajek
3 joint publications
Agnieszka Marczak
3 joint publications
Aneta Rogalska
2 joint publications
Agnieszka Śliwińska
1 joint publications
Damian Kołat
1 joint publications
Elżbieta Płuciennik
1 joint publications
Michał Mikula
1 joint publications
Patrycja Gralewska
1 joint publications
Izabela Szymczak-Pajor
